Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Core EBITDA Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 67.63-48.67-10.49286.35-37.36

What is the latest Core EBITDA Growth ratio of NGL FINECHEM ?

The latest Core EBITDA Growth ratio of NGL FINECHEM is 67.63 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202467.63
Mar2023-48.67
Mar2022-10.49
Mar2021286.35
Mar2020-37.36

How is Core EBITDA Growth of NGL FINECHEM Trending?

Years Core EBITDA Growth % Change
Mar2024 67.63
Positive
Mar2023 -48.67
Negative
Mar2022 -10.49
Negative
Mar2021 286.35
Positive
Mar2020 -37.36 -

Other Financial Ratios of NGL FINECHEM


Compare Core EBITDA Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹694.4 Cr 2.3% -1.4% -56.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,379.0 Cr 0.8% 7.2% 22.2% Stock Analytics
DIVIS LABORATORIES ₹163,420.0 Cr 0.7% 11% 53.3% Stock Analytics
CIPLA ₹122,010.0 Cr -2% 4.6% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,634.0 Cr -1.6% 2.8% 24.4% Stock Analytics
DR REDDYS LABORATORIES ₹96,788.5 Cr -1.4% 0.7% -5.5% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

2.3%

-1.4%

-56.4%

SENSEX

0.5%

4.2%

8%


You may also like the below Video Courses